Published in Hypertension on May 01, 1995
β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis. J Clin Invest (2014) 1.00
Coagulopathy during cardiac arrest and resuscitation in a swine model of electrically induced ventricular fibrillation. Resuscitation (2011) 0.83
The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease. BMC Cardiovasc Disord (2008) 0.82
Hypercoagulability in response to elevated body temperature and central hypovolemia. J Surg Res (2013) 0.76
Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets. J Am Heart Assoc (2017) 0.75
Platelet count and indoor cold exposure among elderly people: A cross-sectional analysis of the HEIJO-KYO study. J Epidemiol (2017) 0.75
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
The present medical database needs reorganization. It's time for a change! Arch Intern Med (1990) 2.02
Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01
Home blood pressure monitoring. Arch Intern Med (2000) 1.71
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Jejunal biopsy in celiac disease. Clin Pediatr (Phila) (1968) 1.57
Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57
Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51
Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49
Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48
Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44
Takayasu's arteritis. Ir Med J (2009) 1.39
Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension (1996) 1.27
Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23
Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22
Hormonal responses to cardiac tamponade: inhibition of release of atrial natriuretic factor despite elevation of atrial pressures. Circulation (1987) 1.19
Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci (1999) 1.17
Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens (1991) 1.15
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15
Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10
Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08
Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Int J Clin Pract (2011) 1.07
There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients. Arch Intern Med (1997) 1.07
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07
Lack of association between a biallelic polymorphism in the adducin gene and blood pressure in whites and African Americans. Am J Hypertens (2000) 1.07
Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med (1990) 1.06
Coliphage 186 Replication is delayed when the host cell is UV irradiated before infection. J Virol (1981) 1.06
Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06
The relationship between pulse volume and blood flow in the finger. Angiology (1967) 1.03
Pneumomediastinum and diabetic hyperpnoea. Br Med J (1968) 1.03
Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03
Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens (2000) 1.02
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest (1987) 1.02
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Hypertension (1998) 1.02
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther (1977) 1.01
Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol (1975) 1.01
Borderline hypertension--a critical review. J Chronic Dis (1971) 1.00
Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. Hypertension (1996) 1.00
Improving cultural awareness and sensitivity training in medical school. Acad Med (1998) 0.99
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens (2001) 0.99
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99
Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension (1995) 0.98
Bleeding during oral anticoagulant therapy. Am Heart J (1966) 0.98
Influence of hypertension on the hemodynamic response to exercise. Circulation (1967) 0.97
The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension. Acta Med Scand (1974) 0.95
Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med (1986) 0.94
Racial differences in erythrocyte cation transport. Hypertension (1984) 0.93
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press (1998) 0.92
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. J Intern Med (2007) 0.92
Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension (1992) 0.92
Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines. N Engl J Med (1982) 0.92
Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension (1998) 0.91
Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study. J Hypertens (2001) 0.91
Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension (1994) 0.90
Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens (1994) 0.90
Congenital pernicious anemia: effects on growth, brain, and absorption of B12. Pediatrics (1968) 0.89
Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Stat Med (1990) 0.89
Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci Mol Med Suppl (1976) 0.89
Stroke volume--pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance. J Hypertens Suppl (1984) 0.89
Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press (2001) 0.89
The contribution of pleiotropy to blood pressure and body-mass index variation: the Gubbio Study. Am J Hum Genet (1994) 0.89
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study. J Hum Hypertens (2004) 0.89
Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension. Circ Res (1975) 0.88
Characterization of a rat alveolar macrophage cell line that expresses a functional mannose receptor. J Leukoc Biol (1998) 0.88
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Press (2001) 0.88
Influences on infant feeding decisions of first-time mothers in five European countries. Eur J Clin Nutr (2012) 0.88
University of California, Davis, conference: Mild hypertension. Am J Med (1988) 0.87
Determinants of baroreflex sensitivity in man. J Lab Clin Med (1978) 0.87
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther (1985) 0.87
Teaching smoking-cessation counseling to medical students using simulated patients. Am J Prev Med (1997) 0.87
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens (1997) 0.87
On the asymmetry of biological frequency distributions. Genet Epidemiol (1990) 0.87
The effect of a standardized patient instructor experience on students' anxiety and confidence levels performing the male genitorectal examination. Teach Learn Med (1997) 0.86
The complex of oriC DNA with the DnaA initiator protein. Res Microbiol (1991) 0.86
Abnormalities of plasma volume in borderline hypertension. Arch Intern Med (1971) 0.86
Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients. Biol Blood Marrow Transplant (2000) 0.86